Skip to main content
ERNAW logo

ERNAW · Ernexa Therapeutics Inc. · Shareholders & Ownership

Track ERNAW — free
$0.03 0.00 (-1.54%) At close · Oct 27
Market Cap
$3.25M
Shares
1.63M
Volume · Oct 27 1912 Avg daily vol (3M) 25.96K

Every disclosed holder of ERNAW in one list: 13F institutions, Schedule 13D and 13G filers, insiders (Forms 3, 4 and 5) and registered funds, each from its own latest filing. Holders nest by CIK and SEC reporting links, never by name, and each is summed once.

Who Owns ERNAW

13F quarter Jun 30, 2026; this listing alone: insiders and shares outstanding are issuer-wide, so they are left out

No chart: shares outstanding cannot be set against these holders.

Holder group Shares % Out
Institutional (13F) 2,836,819 —
Insiders (Forms 3, 4, 5) 0 —
13D/G-only blocks 0 —
Registered funds (N-PORT, not summed) 0 —

% Out is unavailable: shares outstanding is an issuer-wide count, not one listing's.

13D/G-only counts each filer's latest 13D or 13G that no 13F report of the listing contains, that names no 13F filer and that no counted insider files. Funds are never summed: their shares sit inside their advisers' 13F reports.

Holders of ERNAW

# Holder Shares
1
Bleichroeder LP
13F CIK 1781002 · Registered investment adviser · Jun 30, 2026
2,000,000
2
HEIGHTS CAPITAL MANAGEMENT, INC
13F CIK 1081698 · Unknown · Jun 30, 2026
400,000
3
ARMISTICE CAPITAL, LLC
13F CIK 1601086 · Registered investment adviser · Jun 30, 2026
160,000
4
Clear Street Group Inc.
13F CIK 1881567 · Unknown · Jun 30, 2026
149,499
5
Warberg Asset Management LLC
13F CIK 1597506 · Unknown · Jun 30, 2026
69,430
6
SUSQUEHANNA INTERNATIONAL GROUP, LLP
13F CIK 1446194 · Unknown · Jun 30, 2026
57,890

Shares are restated onto today's split basis. Change compares each row with the same holder's previous filing in the same source; a dash means there is none to compare. Nested 13D/G, insider and fund rows are not summed, since a 13F report already holds them.

Key facts CIK 748592 CUSIP 114082407 Visit website Investor relations